aspsirna0230 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0230
siRNA Name: Alpha-SYN-P13
Gene:Synuclein, alpha (SNCA)
Disease:Parkinsons disease (PD)
Wild allele/target (5'->3'): GAAGCAGCAGGAAAGACAA
Mutant allele/target (5'->3'):GAAGCACCAGGAAAGACAA
Target Mutation: c.88G>C,p.Ala30Pro
Wild siRNA (As strand):CUUCGUCGUCCUUUCUGUU
ASP-siRNA (As strand):CUUCGUGGUCCUUUCUGUU
Mismatch position in siRNA: G13C
Mutant allele (5'->3'): GAAGCACCAGGAAAGACAA
ASP-siRNA (As strand):CUUCGUGGUCCUUUCUGUU
ASP-siRNA efficacy for mutant allele:40
Wild allele (5'->3'): GAAGCAGCAGGAAAGACAA
ASP-siRNA (As strand):CUUCGUGGUCCUUUCUGUU
ASP-siRNA efficacy for wild allele:10
Percentage discrimination for ASP-siRNA:30
Wild allele (5'->3'): GAAGCAGCAGGAAAGACAA
Wild siRNA (As strand):CUUCGUCGUCCUUUCUGUU
Wild sirna efficacy for wild allele:High efficacy
Wild allele (5'->3'): GAAGCAGCAGGAAAGACAA
ASP-siRNA (As strand):CUUCGUGGUCCUUUCUGUU
Wild sirna efficacy for mutant allele:Moderate efficacy
Percentage discrimination for wild siRNA:Poor discrimination
Concentration:100nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P37840
Target sequence: AACAGGGUGUGGCAGAAGCAGCAGGAAAGACAAAGAGG
Genbank Accesion: NM_000345.3
Cell-line: HEK293
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Sigma Genosys
Post-transfection duration: 48 hours
OMID ID: 168600
KEGG disease ID:H00057
Reference:22031823

.
.
.
.
.
.
.
.
.
.
.

.

.

.